MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
03:48 EDT 6 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
KENNESAW, Ga., Aug. 2, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that...
Other Sources for this Article
More From BioPortfolio on "MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
